Disclosed herein are certain 4-arylquinazoline derivatives of Formula (I) that are methionine adenosyltransferase 2A (MAT2A) inhibitors. Also disclosed are pharmaceutical compositions comprising such compounds and methods of treating diseases treatable by inhibition of MAT2A such as cancer, including cancers characterized by reduced or absence of methylthioadenosine phosphorylase (MTAP) activity.
                            本文披露了某些Formula (I)的4-芳基
喹唑啉衍
生物,它们是蛋
氨酸
腺苷转移酶2A(MAT2A)
抑制剂。还披露了包含这些化合物的药物组合物以及治疗MAT2A
抑制剂可治疗的疾病的方法,如癌症,包括特征为
甲硫腺苷磷酸化酶(MTAP)活性降低或缺失的癌症。